Jane Street
DERM

Jane Street’s Dermira, Inc. DERM Stock Holding History

Jane Street’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-39,493
Closed -$535K – 6085
2019
Q1 		$535K Buy
39,493
+26,328
+200% +$220K ﹤0.01% 3596
2018
Q4 		$95K Buy
+13,165
New +$144K ﹤0.01% 4638

Other funds holding DERM

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Jane Street's DERM Position: Q2 2019 in Review

Jane Street sold out of Dermira, Inc. (DERM) in Q2 2019, closing a stake of 39,493 shares — an estimated $535K sold.

Jane Street first reported a position in DERM in Q4 2018 and held it in 2 quarters. The position peaked at $535K in Q1 2019. 135 funds tracked by Wall St. Rank hold DERM as of Q2 2019.

  • Jane Street reported no remaining Dermira, Inc. position as of Q2 2019 after selling out during the quarter.
  • Jane Street sold 39,493 Dermira, Inc. shares in Q2 2019, an estimated $535K.
  • Jane Street first reported a position in Dermira, Inc. in Q4 2018 and held it in 2 quarters.
  • Jane Street's Dermira, Inc. position peaked at $535K in Q1 2019.
  • 135 funds tracked by Wall St. Rank held Dermira, Inc. as of Q2 2019.

Based on Jane Street's 13F filing for Q2 2019, filed 15 Aug 2019.